INS and Hyperinsulinemia: Reductions inadiposity lead to improved insulin sensitivity, decreased circulating insulin(hyperinsulinemia can raise BP by renal sodium retention), reduced inflammatorycytokines, and improved vascular function; all of which can lower blood pressure.On average, GLP-1 RA therapy produces significant weight loss over months; thislikely mediates a portion of the blood pressure reduction.